Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Novel Drug Delivery Systems for Women's Health"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (31 May 2023) | Viewed by 4392
Special Issue Editors
Interests: vaginal drug delivery; HIV/STI prevention and contraception; multipurpose prevention technology (MPT) products, vaginal health; user acceptability and adherence; pharmaceutical development and manufacturing in Africa
Interests: HIV /AIDS prevention; wound healing; electrospun fibers; hydrogels; organogels and biogels for transdermal drug delivery and vaginal drug delivery; artificial neural networks
Interests: HIV/AIDS prevention; nanomedicine; mucosal interfacing; vaginal drug delivery; fast dissolving insert
Special Issue Information
Women’s health issues represent a major concern in both research and medical practice. Often dismissed, the specific health needs of women have been underappreciated and targeted scientific research is lacking.
We are focusing this special issue on innovative drug formulation and drug delivery systems that can help address the unmet health needs of women worldwide. Importantly, user acceptability is a key attribute that must be incorporated early in the design and testing of any new delivery system.
Non-gender-specific implantable, injectable, oral, and topical dosage forms can potentially address the unmet needs for women’s health. Meanwhile, cis female-specific products such as vaginally administered fast dissolving inserts, gels, and intravaginal rings can have favorable pharmacological profiles and high user acceptability.
We are interested in drug delivery systems that address a wide range of women’s health needs including vaginal health; contraception and pregnancy; sexually transmitted infections; and genitourinary symptoms of menopause. We encourage submissions that address other women’s health issues as well.
This Special Issue will highlight and capture the latest developments in drug delivery systems for women's health. We invite original and review articles in this field to accelerate scientific knowledge and pharmaceutical advancement.
Dr. Thomas M. Zydowsky
Dr. Margaret Ilomuanya
Dr. Pavimol Angsantikul
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- vaginal drug delivery
- artificial neural network-aided drug design
- sexually transmitted infections including HIV
- multipurpose prevention technology (MPT) products
- management of vaginal and vulvar health
- pregnancy and preterm birth
- gynecological disorders and oncology
- genitourinary symptoms of menopause